Organovo Announces Release Date for Fiscal First-Quarter 2020 Financial Results
18 juil. 2019 08h05 HE
|
Organovo, Inc.
SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 8, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the...
Organovo Presents Data on Creating Stem Cell-Based Bioprinted Kidney Organoids at the International Society for Stem Cell Research (ISSCR) 2019 Annual Meeting
08 juil. 2019 08h05 HE
|
Organovo, Inc.
SAN DIEGO, July 08, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Organovo to Present at Raymond James Life Sciences and MedTech Conference
13 juin 2019 08h05 HE
|
Organovo, Inc.
SAN DIEGO, June 13, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments for Kidney Disease
30 mai 2019 08h05 HE
|
Organovo, Inc.
SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Organovo Updates Key Clinical Development Goals; Company Reports Preliminary Fiscal Fourth-Quarter 2019 Results
22 mai 2019 16h05 HE
|
Organovo, Inc.
- Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2020 - Submit first IND in calendar 2021 SAN DIEGO, May 22, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings,...
Organovo Announces Release Date for Preliminary Fiscal Fourth-Quarter 2019 Financial Results
17 mai 2019 08h05 HE
|
Organovo, Inc.
SAN DIEGO, May 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Wednesday, May 22, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the...
Organovo to Present at 2019 Cell & Gene Meeting on the Mediterranean
17 avr. 2019 08h05 HE
|
Organovo, Inc.
SAN DIEGO, April 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a...
Organovo to Participate in Nash Panel Discussion at 31st Annual Roth Conference
14 mars 2019 08h05 HE
|
Organovo, Inc.
SAN DIEGO, March 14, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will participate in a panel at the 31st Annual ROTH Conference, being held...
Organovo Appoints New Board Member
20 févr. 2019 08h05 HE
|
Organovo, Inc.
SAN DIEGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Third-Quarter 2019 Results
07 févr. 2019 16h05 HE
|
Organovo, Inc.
Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2019Submit first IND in calendar 2020 SAN DIEGO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc....